Variant report
Variant | nsv975924 |
---|---|
Chromosome Location | chr11:55741474-55751535 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:61)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr11:55749566-55749730 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr11:55741577-55741777 | HepG2 | liver: | n/a | chr11:55741709-55741720 |
3 | EP300 | chr11:55743887-55744079 | K562 | blood: | n/a | n/a |
4 | GATA2 | chr11:55751148-55751408 | SH-SY5Y | brain: | n/a | chr11:55751194-55751210 chr11:55751194-55751210 chr11:55751198-55751205 chr11:55751191-55751212 chr11:55751198-55751205 chr11:55751198-55751205 chr11:55751197-55751207 |
5 | GATA3 | chr11:55751213-55751494 | SH-SY5Y | brain: | n/a | n/a |
6 | POLR2A | chr11:55746322-55746356 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | STAT3 | chr11:55745385-55745585 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:55749739-55749789 | CMK | blood: | n/a |
2 | chr11:55749739-55749789 | HAEpiC | amniotic membrane: | n/a |
3 | chr11:55749739-55749789 | AG09319 | gingival: | n/a |
4 | chr11:55749739-55749789 | HCT-116 | colon: | n/a |
5 | chr11:55749739-55749789 | HCF | heart: | n/a |
6 | chr11:55749739-55749789 | H1-hESC | embryonic stem cell: | embryo |
7 | chr11:55749739-55749789 | SK-N-MC | brain: | n/a |
8 | chr11:55749739-55749789 | HCPEpiC | choroid plexus: | n/a |
9 | chr11:55749739-55749789 | SK-N-SH | brain: | n/a |
10 | chr11:55749739-55749789 | HRPEpiC | eye: | n/a |
11 | chr11:55749739-55749789 | HIPEpiC | eye: | n/a |
12 | chr11:55749739-55749789 | K562 | blood: | n/a |
13 | chr11:55749739-55749789 | GM12892 | blood: | n/a |
14 | chr11:55749739-55749789 | LNCaP | prostate: | n/a |
15 | chr11:55749739-55749789 | PrEC | prostate: | n/a |
16 | chr11:55749739-55749789 | HRCEpiC | kidney: | n/a |
17 | chr11:55749739-55749789 | Hela-S3 | cervix: | n/a |
18 | chr11:55749739-55749789 | HEEpiC | esophagus: | n/a |
19 | chr11:55749739-55749789 | MCF10A-Er-Src | breast: | n/a |
20 | chr11:55749739-55749789 | NHBE | bronchial: | n/a |
21 | chr11:55749739-55749789 | GM12891 | blood: | n/a |
22 | chr11:55749739-55749789 | Jurkat | blood: | n/a |
23 | chr11:55749739-55749789 | NH-A | brain: | n/a |
24 | chr11:55749739-55749789 | SAEC | small airway: | n/a |
25 | chr11:55749739-55749789 | BJ | skin: | n/a |
26 | chr11:55749739-55749789 | AG09309 | skin: | n/a |
27 | chr11:55749739-55749789 | SK-N-SH_RA | brain: | n/a |
28 | chr11:55749739-55749789 | AG04449 | skin: | fetal |
29 | chr11:55749739-55749789 | PANC-1 | pancreas: | n/a |
30 | chr11:55749739-55749789 | ovcar-3 | ovarian: | n/a |
31 | chr11:55749739-55749789 | AG10803 | skin: | n/a |
32 | chr11:55749739-55749789 | Caco-2 | colon: | n/a |
33 | chr11:55749739-55749789 | HUVEC | blood vessel: | n/a |
34 | chr11:55749739-55749789 | AoSMC | blood vessel: | n/a |
35 | chr11:55749739-55749789 | GM19239 | blood: | n/a |
36 | chr11:55749739-55749789 | RPTEC | kidney: | n/a |
37 | chr11:55749739-55749789 | HMEC | breast: | n/a |
38 | chr11:55749739-55749789 | NHDF-neo | bronchial: | n/a |
39 | chr11:55749739-55749789 | U87 | brain: | n/a |
40 | chr11:55749739-55749789 | HRE | kidney: | n/a |
41 | chr11:55749739-55749789 | ProgFib | skin: | n/a |
42 | chr11:55749739-55749789 | HNPCEpiC | eye: | n/a |
43 | chr11:55749739-55749789 | HCM | heart: | n/a |
44 | chr11:55749739-55749789 | HPAEpiC | pulmonary alveolar: | n/a |
45 | chr11:55749739-55749789 | NT2-D1 | testis: | n/a |
46 | chr11:55749739-55749789 | HEK293 | kidney: | embryo |
47 | chr11:55749739-55749789 | GM12878 | blood: | n/a |
48 | chr11:55749739-55749789 | T-47D | breast: | n/a |
49 | chr11:55749739-55749789 | MCF-7 | breast: | n/a |
50 | chr11:55749739-55749789 | SKMC | muscle: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR7E5P | TF binding region |
OR7E5P | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540920853 | chr11:55741475-55741476 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs555324511 | chr11:55741482-55741483 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs5791971 | chr11:55741483-55741484 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555887265 | chr11:55741494-55741495 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559935978 | chr11:55741511-55741512 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79525829 | chr11:55741537-55741538 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143284088 | chr11:55741559-55741560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543651610 | chr11:55741592-55741593 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs76105049 | chr11:55741595-55741596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7122038 | chr11:55741619-55741620 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7122142 | chr11:55741637-55741638 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147543431 | chr11:55741699-55741700 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs61051008 | chr11:55741739-55741740 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561407427 | chr11:55741748-55741749 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561916647 | chr11:55741753-55741754 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140280768 | chr11:55741774-55741775 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs550193470 | chr11:55741838-55741839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565379609 | chr11:55741861-55741862 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143518650 | chr11:55741872-55741873 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532607821 | chr11:55741977-55741978 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551626466 | chr11:55742089-55742090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs61896183 | chr11:55742104-55742105 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs533735008 | chr11:55742145-55742146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549302813 | chr11:55742182-55742183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs61896184 | chr11:55742185-55742186 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs140802002 | chr11:55742197-55742198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs61896234 | chr11:55742198-55742199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537851819 | chr11:55742225-55742226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555701185 | chr11:55742235-55742236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138648078 | chr11:55742253-55742254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12273182 | chr11:55742259-55742260 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs538318355 | chr11:55742268-55742269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs201557092 | chr11:55742277-55742278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs61896235 | chr11:55742289-55742290 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs61896236 | chr11:55742424-55742425 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs117298249 | chr11:55742435-55742436 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs185378965 | chr11:55742485-55742486 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs576609490 | chr11:55742491-55742492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543845688 | chr11:55742520-55742521 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs36070669 | chr11:55742532-55742533 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs61896237 | chr11:55742589-55742590 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs547947998 | chr11:55742593-55742594 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559585878 | chr11:55742594-55742595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs11231725 | chr11:55742653-55742654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190231025 | chr11:55742665-55742666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560062359 | chr11:55742727-55742728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs529198896 | chr11:55742748-55742749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs61896238 | chr11:55742754-55742755 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs554791101 | chr11:55742778-55742779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549385444 | chr11:55742792-55742793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 17142309 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20967226 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:55741200-55742000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr11:55741400-55746000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
3 | chr11:55742000-55742400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
4 | chr11:55742400-55742600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr11:55742600-55745600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
6 | chr11:55745600-55747000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr11:55745800-55747000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr11:55746000-55746800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr11:55746000-55746800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr11:55746000-55746800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr11:55746200-55747200 | Enhancers | H9 Cell Line | embryonic stem cell |
12 | chr11:55746200-55747400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr11:55746600-55747400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
14 | chr11:55746800-55747400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr11:55747400-55753000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |